By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus is bearish on ARM, citing extreme valuation (356x trailing earnings) and risks such as architectural displacement by hyperscalers shifting to open ISAs like RISC-V, which could permanently compress ARM's royalty base.
Risk: Architectural displacement by hyperscalers shifting to open ISAs like RISC-V
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Arm stock has soared in 2026.
Arm stock is trading at a rich valuation, so investors may be more comfortable investing in an AI ETF.
Thanks in large part to the market's rampant enthusiasm for artificial intelligence (AI) stocks, Arm Holdings (NASDAQ: ARM) stock has soared more than 210% since the start of 2026, and one firm thinks that the stock is poised to rocket even higher. This new, bullish outlook on Arm stock is driving the semiconductor stock higher during today's market session.
As of 11:36 a.m. ET, shares of Arm are up 13%.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Maintaining an outperform rating, Mizuho hiked its price target on Arm stock to $360 from $290. According to Thefly.com, the firm raised its price target on the belief that demand for dynamic random access memory (DRAM), a type of computer memory used to temporarily store data that your computer is actively using, will remain strong through 2027; moreover, Mizuho recognizes that the high bandwidth memory's total addressable market is growing -- two factors that bode well for semiconductor specialist Arm.
Based on Arm's closing price of $302.71, the new price target implies upside of 19%. Should Arm stock, in fact, rise to $360, it will represent a new all-time high. As of this writing, Arm's intraday high was $345.60 earlier today.
While Mizuho sees Arm stock continuing to rise, investors should bear in mind that shares are trading at a steep valuation -- about 356 times trailing earnings. In light of this, AI investors may be more comfortable investing in an AI ETF that includes Arm stock among its holdings to gain exposure to Arm stock.
Before you buy stock in Arm Holdings, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Arm Holdings wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $471,072! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,303,352!
Now, it’s worth noting Stock Advisor’s total average return is 983% — a market-crushing outperformance compared to 210% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 28, 2026. *
Scott Levine has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"ARM's 356x trailing earnings already prices in perfection, leaving little margin for the execution risks the Mizuho note glosses over."
Mizuho's $360 target on ARM implies just 19% upside from the $302.71 close, yet the stock already trades at 356x trailing earnings after a 210% run in 2026. The cited drivers—sustained DRAM demand and expanding HBM TAM—are indirect at best for a company whose revenue comes from IP licensing, not memory production. At these multiples, any slowdown in AI capex or loss of design wins would trigger sharp derating. Investors chasing the headline may overlook that ARM's growth is already fully priced in, favoring an ETF for diluted exposure instead.
If AI-driven chip demand accelerates beyond 2027 forecasts, ARM's royalty stream could compound fast enough to justify even higher multiples before mean reversion occurs.
"A 356x trailing P/E multiple on a semiconductor design company leaves no room for demand disappointment, and Mizuho's upgrade reads more like momentum-chasing than fundamental repricing."
Mizuho's $360 target implies 19% upside from $302.71, but ARM trades at 356x trailing earnings — a valuation that leaves zero margin for error on execution. The bull case hinges entirely on sustained DRAM and HBM demand through 2027, but the article provides zero evidence this demand is accelerating *now* versus priced-in. ARM's 210% YTD gain already reflects AI enthusiasm; Mizuho's upgrade appears reactive rather than forward-looking. The real risk: if HBM adoption slows or inventory normalizes, this stock has no valuation cushion. The article also conveniently omits ARM's actual revenue growth rate and operating leverage — critical for justifying a 356x multiple.
If HBM TAM truly is expanding and ARM's design wins are locked in through 2027, then current valuation may be justified on a PEG basis (price-to-earnings-growth ratio), and the stock could reach $360 without a bubble — especially if earnings grow 40%+ annually.
"Arm's 356x P/E ratio represents an unsustainable valuation bubble that ignores both cyclical semiconductor risks and the long-term threat of open-source competition like RISC-V."
Mizuho’s $360 price target feels like a classic case of chasing momentum rather than fundamentals. While Arm’s architecture is undeniably central to the AI compute stack, a 356x trailing P/E ratio is not just 'rich'—it is detached from reality. The market is pricing in perfect execution for years, ignoring the cyclical nature of semiconductors and the reality that Arm’s royalty model faces margin pressure if customers pivot to open-source alternatives like RISC-V. Betting on Arm here requires ignoring the law of large numbers; the stock is trading on a narrative of scarcity that may evaporate if AI CAPEX spending cools, leaving investors holding a massive valuation premium with shrinking growth catalysts.
If Arm successfully captures higher royalty rates via its new v9 architecture and expands significantly into data center and automotive markets, the current P/E is a misleading metric that fails to account for massive future operating leverage.
"Arm’s upside hinges on a sustained AI capex boom and durable licensing economics; without that, the current valuation is vulnerable to multiple compression."
Arm's run is driven more by AI hype than near-term earnings visibility. The stock’s 210% YTD rise and a $360 bull case imply belief in durable licensing royalties from data-center, smartphone, and edge AI workloads, plus memory-bandwidth demand (HBM/DRAM) that should keep Arm's customers investing. Yet the valuation is extreme: around 356x trailing earnings, with most upside hinging on outsized licensing gains and margin stability. Key risks: a cooldown in AI capex or slower-than-expected server refresh cycles, competition from open ISAs like RISC-V, and regulatory/licensing headwinds that could compress royalties or deter customers.
Strongest counter: AI demand could stall, cutting royalty growth; and Arm's revenue quality depends on licensing terms that customers can push back on, or on alternative CPU architectures (RISC-V) gaining traction, risking multiple compression.
"Minimum royalty guarantees and licensee concentration create asymmetric downside not captured in pure multiple critiques."
Claude notes the missing revenue growth data, yet everyone underplays how ARM's royalty contracts often embed minimum guarantees that buffer against near-term AI capex pauses. This contractual floor could slow any derating even if HBM demand normalizes by 2026, provided design wins stay intact. The bigger unmentioned threat is customer concentration: if Nvidia or other licensees accelerate custom silicon that reduces ARM IP usage, the 356x multiple compresses faster than the cyclical risks already discussed.
"RISC-V adoption by hyperscalers is a structural TAM risk that's orthogonal to AI capex cycles and harder to price than cyclical derating."
Grok's minimum guarantee floor is plausible but unverified here—the article doesn't cite contract terms. More critically, everyone assumes design wins stay intact, yet that's precisely where RISC-V poses real threat. If a major licensee (say, a hyperscaler) shifts even 20% of new silicon to open ISA, ARM's royalty base shrinks without capex cooling at all. That's architectural displacement, not cyclical risk. Valuation then reprices on lower TAM, not just lower multiples.
"The risk of architectural displacement via RISC-V is a permanent threat to ARM's royalty base that renders current valuation multiples fundamentally unsustainable."
Claude, you hit the nail on the head regarding architectural displacement. Everyone is obsessing over the 356x P/E, but the real existential threat is the 'hyperscaler pivot.' If Amazon or Google shifts even a fraction of their internal silicon to RISC-V, the royalty decay is permanent, not cyclical. You’re right to ignore the 'minimum guarantee' floor—that’s just a temporary accounting cushion that won't stop a structural valuation reset if the IP moat begins to crack.
"Structural risk from open ISA displacement could reprice ARM's multiple even if near-term demand stays intact."
Claude, your risk framing is fair, but the article omits a structural threat: even with HBM/DRAM demand and design-wins, a material shift to open ISAs (RISC-V) by hyperscalers could permanently compress ARM's royalty base, not just capex timing. A floor on royalties only helps if contracts actually enforce it; without transparency on terms, the risk is a sudden multiple derating if the licensee mix shifts. Watch licensee concentration and elasticity of royalties, not just TAM.
The panel consensus is bearish on ARM, citing extreme valuation (356x trailing earnings) and risks such as architectural displacement by hyperscalers shifting to open ISAs like RISC-V, which could permanently compress ARM's royalty base.
Architectural displacement by hyperscalers shifting to open ISAs like RISC-V